MEKK1-induced apoptosis is mediated by Smac/Diablo release from the mitochondria

Biochemical and Biophysical Research Communications

Volumn 331, Issue 4, 2005, Pages 1089-1098

  Mendoza, Francisco J ^a   Henson, Elizabeth S ^a   Gibson, Spencer B ^a  

^a NONE

Author keywords

Apoptosis; JNK; MEKK1; Mitochondria; Smac Diablo

Indexed keywords

CYTOCHROME C; ETOPOSIDE; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CORRELATION ANALYSIS; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; CYTOCHROMES C; ETOPOSIDE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAP KINASE KINASE KINASE 1; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEINS; RNA, SMALL INTERFERING; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 18844399612     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.234     Document Type: Article

References (40)

1. C. Widmann, S. Gibson, and G.L. Johnson Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals J. Biol. Chem. 273 1998 7141 7147
2. C. Widmann, N.L. Johnson, A.M. Gardner, R.J. Smith, and G.L. Johnson Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1 Oncogene 15 1997 2439 2447
3. C. Widmann, P. Gerwins, N.L. Johnson, M.B. Jarpe, and G.L. Johnson MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis Mol. Cell. Biol. 18 1998 2416 2429
4. C.A. Lange-Carter, C.M. Pleiman, A.M. Gardner, K.J. Blumer, and G.L. Johnson A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf Science 260 1993 315 319
5. Y.R. Chen, and T.H. Tan The c-Jun N-terminal kinase pathway and apoptotic signaling (review) Int. J. Oncol. 16 2000 651 662
6. M. Leist, and M. Jaattela Four deaths and a funeral: from caspases to alternative mechanisms Nat. Rev. Mol. Cell Biol. 2 2001 589 598
7. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
8. E.M. Gibson, E.S. Henson, J. Villanueva, and S.B. Gibson MEK kinase 1 induces mitochondrial permeability transition leading to apoptosis independent of cytochrome c Release J. Biol. Chem. 277 2002 10573 10580
9. X. Saelens, N. Festjens, L. Vande Walle, M. van Gurp, G. van Loo, and P. Vandenabeele Toxic proteins released from mitochondria in cell death Oncogene 23 2004 2861 2874
10. Y. Deng, X. Ren, L. Yang, Y. Lin, and X. Wu A JNK-dependent pathway is required for TNFalpha-induced apoptosis Cell 115 2003 61 70
11. Y. Deng, Y. Lin, and X. Wu TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO Genes Dev. 16 2002 33 45
12. D. Chauhan, T. Hideshima, S. Rosen, J.C. Reed, S. Kharbanda, and K.C. Anderson Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells J. Biol. Chem. 276 2001 24453 24456
13. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, and X. Wang Biochemical pathways of caspase activation during apoptosis Annu. Rev. Cell Dev. Biol. 15 1999 269 290
14. G.S. Salvesen, and C.S. Duckett IAP proteins: blocking the road to death's door Nat. Rev. Mol. Cell Biol. 3 2002 401 410
15. S.M. Srinivasula, R. Hegde, A. Saleh, P. Datta, E. Shiozaki, J. Chai, R.A. Lee, P.D. Robbins, T. Fernandes-Alnemri, Y. Shi, and E.S. Alnemri A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis Nature 410 2001 112 116
16. C. Widmann, S. Gibson, M.B. Jarpe, and G.L. Johnson Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human Physiol. Rev. 79 1999 143 180
17. H. Okada, W.K. Suh, J. Jin, M. Woo, C. Du, A. Elia, G.S. Duncan, A. Wakeham, A. Itie, S.W. Lowe, X. Wang, and T.W. Mak Generation and characterization of Smac/DIABLO-deficient mice Mol. Cell. Biol. 22 2002 3509 3517
18. T. Yujiri, M. Ware, C. Widmann, R. Oyer, D. Russell, E. Chan, Y. Zaitsu, P. Clarke, K. Tyler, Y. Oka, G.R. Fanger, P. Henson, and G.L. Johnson MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation Proc. Natl. Acad. Sci. USA 97 2000 7272 7277
19. M. Kohli, J. Yu, C. Seaman, A. Bardelli, K.W. Kinzler, B. Vogelstein, C. Lengauer, and L. Zhang SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells Proc. Natl. Acad. Sci. USA 101 2004 16897 16902
20. S. Fulda, W. Wick, M. Weller, and K.M. Debatin Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo Nat. Med. 8 2002 808 815
21. L. Yang, T. Mashima, S. Sato, M. Mochizuki, H. Sakamoto, T. Yamori, T. Oh-Hara, and T. Tsuruo Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide Cancer Res. 63 2003 831 837
22. F.J. Mendoza, P.S. Espino, K.L. Cann, N. Bristow, K. McCrea, and M. Los Anti-tumor chemotherapy utilizing peptide-based approaches-apoptotic pathways, kinases, and proteasome as targets Arch. Immunol. Ther. Exp. (Warsz) 53 2005 47 60
23. C.R. Arnt, and S.H. Kaufmann The saintly side of Smac/DIABLO: giving anticancer drug-induced apoptosis a boost Cell Death Differ. 10 2003 1118 1120
24. C. Denicourt, and S.F. Dowdy Medicine. Targeting apoptotic pathways in cancer cells Science 305 2004 1411 1413
25. M. Madesh, B. Antonsson, S.M. Srinivasula, E.S. Alnemri, and G. Hajnoczky Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization J. Biol. Chem. 277 2002 5651 5659
26. M. Gorka, M.M. Godlewski, B. Gajkowska, U. Wojewodzka, and T. Motyl Kinetics of Smac/DIABLO release from mitochondria during apoptosis of MCF-7 breast cancer cells Cell Biol. Int. 28 2004 741 754
27. K. Kandasamy, S.M. Srinivasula, E.S. Alnemri, C.B. Thompson, S.J. Korsmeyer, J.L. Bryant, and R.K. Srivastava Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release Cancer Res. 63 2003 1712 1721
28. T. Yujiri, S. Sather, G.R. Fanger, and G.L. Johnson Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption Science 282 1998 1911 1914
29. K. Yamamoto, H. Ichijo, and S.J. Korsmeyer BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M Mol. Cell. Biol. 19 1999 8469 8478
30. A.H. Bild, F.J. Mendoza, E.M. Gibson, M. Huang, J. Villanueva, T.P. Garrington, R. Jove, G.L. Johnson, and S.B. Gibson MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage Oncogene 21 2002 6649 6656
31. S. Gibson, C. Widmann, and G.L. Johnson Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents J. Biol. Chem. 274 1999 10916 10922
32. J. Sadoshima, O. Montagne, Q. Wang, G. Yang, J. Warden, J. Liu, G. Takagi, V. Karoor, C. Hong, G.L. Johnson, D.E. Vatner, and S.F. Vatner The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy J. Clin. Invest. 110 2002 271 279
33. K. Shimada, S. Matsuyoshi, M. Nakamura, E. Ishida, M. Kishi, and N. Konishi Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis Carcinogenesis 25 2004 1089 1097
34. A. Huwiler, C. Xin, A.K. Brust, V.A. Briner, and J. Pfeilschifter Differential binding of ceramide to MEKK1 in glomerular endothelial and mesangial cells Biochim. Biophys. Acta 1636 2004 159 168
35. A. Jurewicz, M. Matysiak, K. Tybor, and K. Selmaj TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3 Brain 126 2003 1358 1370
36. S. Boldt, U.H. Weidle, and W. Kolch The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways Exp. Cell Res. 283 2003 80 90
37. S.Y. Fuchs, V. Adler, M.R. Pincus, and Z. Ronai MEKK1/JNK signaling stabilizes and activates p53 Proc. Natl. Acad. Sci. USA 95 1998 10541 10546
38. I. Tamm, S.M. Kornblau, H. Segall, S. Krajewski, K. Welsh, S. Kitada, D.A. Scudiero, G. Tudor, Y.H. Qui, A. Monks, M. Andreeff, and J.C. Reed Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias Clin. Cancer Res. 6 2000 1796 1803
39. I. Tamm, M. Trepel, M. Cardo-Vila, Y. Sun, K. Welsh, E. Cabezas, A. Swatterthwait, W. Arap, J.C. Reed, and R. Pasqualini Peptides targeting caspase inhibitors J. Biol. Chem. 278 2003 14401 14405
40. A.D. Schimmer, K. Welsh, C. Pinilla, Z. Wang, M. Krajewska, M.J. Bonneau, I.M. Pedersen, S. Kitada, F.L. Scott, B. Bailly-Maitre, G. Glinsky, D. Scudiero, E. Sausville, G. Salvesen, A. Nefzi, J.M. Ostresh, R.A. Houghten, and J.C. Reed Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity Cancer Cell 5 2004 25 35